Reducing the risk of recurrent preterm births using probiotics
Researchers in Japan found that taking probiotics early in pregnancy may help reduce the risk of spontaneous preterm delivery. A multicenter clinical trial showed that women who consumed probiotics containing Clostridium butyricum had lower recurrence rates compared to national averages.
Preterm birth is a major cause of neonatal illness and death. Researchers in Japan explored whether probiotics could help reduce this risk. They conducted a clinical trial with 315 pregnant women who had previously experienced spontaneous preterm delivery. The women received probiotic tablets containing Clostridium butyricum from 10-14 weeks of pregnancy until 36 weeks and 6 days of gestation. The results showed a lower recurrence rate of spontaneous preterm delivery compared to national averages. The probiotic regimen was found to be safe with no serious adverse events reported. This study suggests that probiotic therapy may be a simple strategy to help prevent premature births.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.